Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis

Inflammatory Bowel Diseases

Volumn 11, Issue 8, 2005, Pages 744-748

  Erichsen, Kari ^a,b   Milde, Anne Marita ^b   Arslan, Gülen ^b,c   Helgeland, Lars ^a   Gudbrandsen, Oddrun Anita ^b   Ulvik, Rune J ^a,b   Berge, Rolf K ^b   Hausken, Trygve ^a,b   Berstad, Arnold ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c INSTITUTE OF MARINE RESEARCH   (Norway)

Author keywords

Colitis; Dextran sulfate; Iron; Oxidative stress; Rats

Indexed keywords

AMINOTHIOL; ANTIOXIDANT; DEXTRAN SULFATE; FERROUS FUMARATE; HYDROXYL RADICAL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RETINOL;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DRUG INDUCED DISEASE; ENTERITIS; IRON ABSORPTION; IRON THERAPY; LIPID BLOOD LEVEL; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; BIOPSY, NEEDLE; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FERROUS COMPOUNDS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; OXIDATIVE STRESS; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 24644524039     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000174374.83601.86     Document Type: Article

References (28)

1. Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190-1197.
2. Carrier J, Aghdassi E, Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther. 2001;15:1989-1999.
3. Oldenburg B, Berge Henegouwen GP, Rennick D, et al. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest. 2000;30:505-510.
4. Uritski R, Barshack I, Bilkis I, et al. Dietary iron affects inflammatory status in a rat model of colitis. J Nutr. 2004;134:2251-2255.
5. Gaudio E, Taddei G, Vetuschi A, et al. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci. 1999;44:1458-1475.
6. Somasundaram S, Sigthorsson G, Simpson RJ, et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther. 2000;14:639-650.
7. Milde AM, Sundberg H, Roseth AG, et al. Proactive sensitizing effects of acute stress on acoustic startle responses and experimentally induced colitis in rats: relationship to corticosterone. Stress. 2003;6:49-57.
8. Vaagenes H, Muna ZA, Madsen L, et al. Low doses of eicosapentaenoic acid, docosahexaenoic acid, and hypolipidemic eicosapentaenoic acid derivatives have no effect on lipid peroxidation in plasma. Lipids. 1998;33:1131-1137.
9. Svardal AM, Mansoor MA, Ueland PM. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem. 1990;184:338-346.
10. Mahmud T, Somasundaram S, Sigthorsson G, et al. Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat. Gut. 1998;43:775-782.
11. Reifen R, Matas Z, Zeidel L, et al. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci. 2000;45:394-397.
12. Seril DN, Liao J, Ho KL. et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci. 2002;47:1266-1278.
13. Carrier J, Aghdassi E, Cullen J. et al. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr. 2002;132:3146-3150.
14. Reifen R, Nissenkorn A, Matas Z, et al. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol. 2004;39:514-519.
15. Andrews NC. Intestinal iron absorption: current concepts circa 2000. Dig Liver Dis. 2000;32:56-61.
16. Harvey RS, Reffitt DM, Doig LA, et al. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron. Aliment Pharmacol Ther. 1998;12:845-848.
17. Lund EK, Wharf SG, Fairweather-Tait SJ, et al. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr. 1999;69:250-255.
18. Harris ML, Schiller HJ, Reilly PM, et al. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol Ther. 1992;53:375-408.
19. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41:1819-1828.
20. Kristinsson J, Nygaard K, Sundseth A, et al. Comparison of faecal and intestinal concentrations of granulocyte marker protein and localization of gastrointestinal tumours in rats. Scand J Gastroenterol. 2002;37:1029-1033.
21. Hans W, Scholmerich J, Gross V, et al. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol. 2000;12:267-273.
22. Osman N, Adawi D, Ahrne S, et al. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig Dis Sci. 2004;49:320-327.
23. Rumi G, Tsubouchi R, Okayama M, et al. Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig Dis Sci. 2004;49:1466-1472.
24. Benoni G, Cuzzolin L, Zambreri D, et al. Gastrointestinal effects of single and repeated doses of ferrous sulphate in rats. Pharmacol Res. 1993;27:73-80.
25. Perl DP, Fogarty U, Harpaz N, et al. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis. 2004;10:881-883.
26. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116(Suppl 7A):44S-49S.
27. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet. 1994;344:859-861.
28. Guslandi M. Antibiotics for inflammatory bowel disease: do they work? Eur J Gastroenterol Hepatol. 2005;17:145-147.